Comparison of effectiveness of topical tacrolimus and betamethasone with soft paraffin in the treatment of patchy alopecia areata

Pakistan Journal of Medical Sciences

Volumn 25, Issue 5, 2009, Pages 833-836

  Saleem, Azra ^a   Khan, Moosa ^a   Mashori, Ghulam Rasool ^a   Samdanl, Azam ^a   Asif Jahanzeb Kazmi, S ^a  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

Alopecia areata; Betamethasone; Tacrolimus

Indexed keywords

BETAMETHASONE; BETAMETHASONE VALERATE; LIQUID PARAFFIN; TACROLIMUS; TACZEM; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; BURNING SENSATION; CHILD; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROL GROUP; DISEASE COURSE; DRUG EFFICACY; DRUG INDICATION; DRUG WITHDRAWAL; FEMALE; FOLLICULITIS; GROWTH RATE; HAIR GROWTH; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATCHY ALOPECIA AREATA; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; TREATMENT DURATION;

EID: 70350595958     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Epstein E.Evidence based treatment of alopecia areata. JamAcad Dermatol 2001;45:640-642 (Pubitemid 32917271)
2. Sharma VK.Dawn G.Kumar B.Profile of alopecia areata in northern India. Int J Dermatol 1996;35:22-27
3. Firoz A, Firozabadi MR, Ghazisaidi B, Dowlati Y. Concepts of patients withalopecia areata about their disease. BMC Dermatol 2005;5:1-5. (Pubitemid 41363836)
4. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ, Incidrnce of alopecia areata in Olmsted Country, Minnesota, 1975 through 1989. Mayo Clin Proc 1995;70;628-633
5. Strober BE, Siu K. Alexis AF, Kim G, Washenik K. Sinha A, et al. Etanercept does not effectively treat moderate to severe alopecia areata; An open-lable study. J Am Acad Dermatol 2005;52:1082-1084 (Pubitemid 40732553)
6. Mc-Donagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermotal 2002;27:405-409
7. Tang L, Lui H, Sundberg JP, Bissonnette R, McLean DI, Shapiro J. Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata. J Am Acad Dermatol 2003;49:1013-1019 (Pubitemid 37475471)
8. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998;101:62-67 (Pubitemid 28058903)
9. Shaprio J. Price VH, Hair regrowth. Therapeutic agents. Dermatol Clin 1998;16:341-356
10. Hoffmann R. Happle R. Topical immunotherapy in alopecia areata; what, how and why? Dermatol Clin 1996;14:739-744
11. Fiedler VC. Alaiti S. Treatment of alopecia areata. Dermatol Clin 1996;14:733-737
12. Schmidt S, Fischer TW, Chren MM. Strategies of coping and quality of life in women with alopecia. Br J Dermatol 2001;144:1038-1043 (Pubitemid 34203358)
13. Shapiro J. Price V. Hair regrowth: Therapeutic agents. Dermatol Clin 1998;16:341-356.
14. Charuwhicitratanas. Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream. Arch Dermatol 2000;10:241-243.
15. Price VH, Willey A, Chen BK. Topical tacrolimus in alopecia areata. J Am Acad Dermatol 2005;52(1):138-139
16. Ruzicka T, Assman T, Lebwohl M. Indications of topical tacrolimus. Eur J Dermatol 2003; 13(4):331-342
17. Desouza. Vaseline and burns. Vaseline should not be used as first aid for burns. BMJ 2008;21(6):1078.
18. Taylor CR, Hawk JL. PUVA treatment of alopecia areata partialis, totalis and universalis. Br J Dermatol 2006;133(6):914.
19. Sharma Feldmann KA, Kunte C, Wollenberg A, Wolfe H. Is topical tacrolimus effective in alopecia areata universalis? Br J Dermatol 2002;147(5):1031-1032